<SEC-DOCUMENT>0001683168-24-007319-index.html : 20241023
<SEC-HEADER>0001683168-24-007319.hdr.sgml : 20241023
<ACCEPTANCE-DATETIME>20241023141057
ACCESSION NUMBER:		0001683168-24-007319
CONFORMED SUBMISSION TYPE:	SC 13G
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20241023
DATE AS OF CHANGE:		20241023
GROUP MEMBERS:		PETER E. DEUTSCH

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Spyre Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001636282
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				464312787
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-89456
		FILM NUMBER:		241388829

	BUSINESS ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453
		BUSINESS PHONE:		6176515940

	MAIL ADDRESS:	
		STREET 1:		221 CRESCENT STREET
		STREET 2:		BUILDING 23, SUITE 105
		CITY:			WALTHAM
		STATE:			MA
		ZIP:			02453

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Aeglea BioTherapeutics, Inc.
		DATE OF NAME CHANGE:	20150311

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Deutsch Peter E.
		CENTRAL INDEX KEY:			0001998610
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		SC 13G

	MAIL ADDRESS:	
		STREET 1:		25 EAST POINT LANE
		CITY:			OLD GREENWICH
		STATE:			CT
		ZIP:			06870
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G
<SEQUENCE>1
<FILENAME>deutsch_13g.htm
<DESCRIPTION>SCHEDULE 13G
<TEXT>
Document 1 - file: deutsch_13g.htm

</DOCUMENT>
</SEC-DOCUMENT>